ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2017)
ENDRA Life Sciences' (NDRA) quarterly Cost of Revenue came in at $3085.0 in Q4 2017, down 98.69% year-over-year from $235878.0 in Q4 2016, and down 97.39% quarter-over-quarter from $118270.0 in Q3 2017.
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2017) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Cost of Revenue for 2 consecutive years, with $3085.0 the latest figure, recorded in Q4 2017.
- On a quarterly basis, Cost of Revenue fell 98.69% year-over-year to $3085.0 in Q4 2017; TTM through Sep 2018 was $3085.0, a 99.24% decrease from a year earlier, with the FY2017 full-year figure at $172782.0, down 26.75% from the prior year.
- Cost of Revenue was $3085.0 for Q4 2017 at ENDRA Life Sciences, down from $118270.0 in the prior quarter.
- Over five years, Cost of Revenue peaked at $235878.0 in Q4 2016 and troughed at $3085.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 2.25 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 146.33 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | 10.89 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 117.50 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | 9.32 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 2.16 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 133.80 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 3,085.00 |
| Sep 30, 2017 | 118,270.00 |
| Jun 30, 2017 | 51,427.00 |
| Dec 31, 2016 | 235,878.00 |